Publication | Open Access

Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus

VaccinationAdenoviral VectorVaccine DevelopmentImmunologyViral PathogenesisHeterologous Prime–boost VaccinationVirologyT Cell ImmunityVaccine DesignMedicineViral ImmunityProtein Nanoparticles